Abstract
To address the hypothesis that certain disease-associated mutants of the breast-ovarian cancer susceptibility gene BRCA1 have biological activity in vivo, we have expressed a truncated Brca1 protein (trBrca1) in cell-lines and in the mammary gland of transgenic mice. Immunofluorescent analysis of transfected cell-lines indicates that trBRCA1 is a stable protein and that it is localized in the cell cytoplasm. Functional analysis of these cell-lines indicates that expression of trBRCA1 confers an increased radiosensitivity phenotype on mammary epithelial cells, consistent with abrogation of the BRCA1 pathway. MMTV-trBrca1 transgenic mice from two independent lines displayed a delay in lactational mammary gland development, as demonstrated by altered histological profiles of lobuloalveolar structures. Cellular and molecular analyses indicate that this phenotype results from a defect in differentiation, rather than altered rates of proliferation or apoptosis. The results presented in this paper are consistent with trBrca1 possessing dominant-negative activity and playing an important role in regulating normal mammary development. They may also have implications for germline carriers of BRCA1 mutations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amundadottir LT, Merlino G and Dickson RB (1996) Transgenic mouse models of breast cancer. Breast Cancer Res Treat 39: 119–135.
Brugarolas J and Jacks T (1997) Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental ar-rest in Brca1 and Brca2 null mice, suggesting a role for fa-milial breast cancer genes in DNA damage repair. Nat Med 3: 721–722.
Connor F, Bertwistle D, Mee PJ, Ross GM, Swift S, Grigorieva E et al. (1997) Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat Genet 17: 423–430.
Deng CX and Brodie SG (2000) Roles of BRCA1 and its interacting proteins. Bioessays 22: 728–737.
Englert C, Vidal M, Maheswaran S, Ge Y, Ezzell RM, Isselbacher KJ et al. (1995) Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc Natl Acad Sci USA 92: 11960–11964.
Fan S, Yuan R-Q, Ma YX, Meng Q, Goldberg ID and Rosen EM (2001) Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1. Oncogene 20: 8215–8235.
Foray N, Randrianarison V, Marot D, Perricaudet M, Lenoir G and Feunteun J (1999) Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene 18: 7334-7342.
Gudas JM, Nguyen H, Li T and Cowan KH (1995) Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 55: 4561–4565.
Haber DA, Timmers HT, Pelletier J, Sharp PA and Housman DE (1992) A dominant mutation in the Wilms tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells. Proc Natl Acad Sci USA 89: 6010-6014.
Harvey M, Vogel H, Morris D, Bradley A, Bernstein A and Done-hower LA (1995) A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nat Genet 9: 305–311.
Jackson D, Bresnick J, Rosewell I, Crafton T, Poulsom R, Stamp G et al. (1997) Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland. J Cell Sci 110: 1261–1268.
Jernstrom H, Johannsson O, Borg A, Ivarsson H and Olsson H (1998) BRCA1-positive patients are small for gestational age compared with their unaffected relatives. Eur J Cancer 34: 368–371.
Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW and Vogelstein B (1992) Oncogenic forms of p53 inhibit p53 regulated gene expression. Science 256: 827–830.
Kinzler KW and Vogelstein B (1997) Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386: 761–763.
Lane TF, Deng C, Elson A, Lyu MS, Kozak CA and Leder P (1995) Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev 9: 2712–2722.
Larson JS, Tonkinson JL and Lai MT (1997) A BRCA1 mutant al-ters G2-M cell cycle control in human mammary epithelial cells. Cancer Res 57: 3351–3355.
Lindeman GJ, Wittlin S, Lada H, Naylor MJ, Santamaria M, Zhang JG et al. (2001) SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. Genes Dev 15: 1631–1636.
Marks JR, Huper G, Vaughn JP, Davis PL, Norris J, McDonnell DP et al. (1997) BRCA1 expression is not directly responsive to estrogen. Oncogene 14: 115–121.
Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ et al. (1995) The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11: 17–26.
Morgan SE, Lovly C, Pandita TK, Shiloh Y and Kastan MB (1997) Fragments of ATM which have dominant-negative or complementing activity. Mol Cell Bio l17: 2020–2029.
Nicolaides NC, Littman SJ, Modrich P, Kinzler KW and Vogelstein B (1998) A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype. Mol Cell Biol 18: 1635-1641.
Pullan SE and Streuli CH (1996) The mammary gland epithelial cells. In: Harris A (ed.), Epithelial Cell Culture. (pp 97–121) Cambridge University Press.
Robinson GW, McKnight RA, Smith GH and Hennighausen L (1995) Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 121: 2079–2090.
Stewart T, Pattengale PK and Leder P (1984) Spontaneous mam-mary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38: 627–637.
Thangaraju M, Kaufmann SH and Couch FJ (2000) BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines. J BiolChem 275: 33487–33496.
Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T et al. (1999) Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22: 37–43.
Zhang H, Somasundaram K, Peng Y, Tian H, Bi D, Weber BL et al. (1998) BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16: 1713–1721.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brown, M.A., Nicolai, H., Howe, K. et al. Expression of a Truncated Brca1 Protein Delays Lactational Mammary Development in Transgenic Mice. Transgenic Res 11, 467–478 (2002). https://doi.org/10.1023/A:1020348025139
Issue Date:
DOI: https://doi.org/10.1023/A:1020348025139